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Summary
Current, high-quality data are needed to evaluate the health impact
of the epidemic of obesity in Latin America. The Latin American
Consortium of Studies of Obesity (LASO) has been established,
with the objectives of (i) Accurately estimating the prevalence of
obesity and its distribution by sociodemographic characteristics; (ii)
Identifying ethnic, socioeconomic and behavioural determinants of
obesity; (iii) Estimating the association between various anthropo-
metric indicators or obesity and major cardiovascular risk factors
and (iv) Quantifying the validity of standard definitions of the
various indexes of obesity in Latin American population. To achieve
these objectives, LASO makes use of individual data from existing
studies. To date, the LASO consortium includes data from 11 studies
from eight countries (Argentina, Chile, Colombia, Costa Rica,
Dominican Republic, Peru, Puerto Rico and Venezuela), including a
total of 32 462 subjects. This article describes the overall organiza-
tion of LASO, the individual studies involved and the overall strategy
for data analysis. LASO will foster the development of collaborative
obesity research among Latin American investigators. More impor-
tant, results from LASO will be instrumental to inform health
policies aiming to curtail the epidemic of obesity in the region.
Keywords: Consortium, health surveys, Latin America, obesity, risk
factors.
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Introduction
The parallel processes of economic growth, migration and
urbanization in Latin America have shaped the epide-
miological transition by increasing life expectancy and
modifying lifestyles (1–3). In fact, the increase in the con-
sumption of high-energy-density foods and the reduction in
the levels of physical activity have been recognized as the
main factors associated with the accelerated epidemic of
obesity in the region (4,5). This epidemic is a matter of
great concern because obesity constitutes a major modifi-
able risk factor for most of the leading causes of disability
and mortality in Latin American countries, particularly
cardiovascular diseases (CVD), diabetes mellitus, osteoar-
thritis and certain types of cancers (6,7).
Although existing evidence suggests a parallel increment
in total energy and fat consumption, the prevalence of
sedentary behaviours and the prevalence of obesity (8–10),
there are limited reliable data on the magnitude and con-
sequences of the epidemic of obesity in the region. Further-
more, the association of behavioural and environmental
factors with obesity, as well as the relationship between
obesity and other chronic diseases, might be more complex
in Latin America than in more homogeneous populations.
In fact, the current definition of obesity, primarily derived
from White populations from Europe and the United States
(6), might not be optimal to identify individuals at high risk
of CVD or of diabetes mellitus (11,12).
Estimates of the prevalence of obesity have shown a great
variability in Latin American populations, ranging from
9.9% to 35.7% (13). Women and individuals living in
urban areas have been identified as the groups predomi-
nantly affected (14). In addition, obesity has been indepen-
dently associated to low socioeconomic status and poorer
educational level (15,16), and contributes to the accentua-
tion of health inequalities in the region (17). There is also
evidence of a secular trend towards the increase in levels
of obesity among the most economically developed Latin
American countries during the past three decades (14,18);
however, similar data are not available for more disadvan-
taged populations. Moreover, most of the information on
obesity has been obtained from nutritional surveys con-
ducted during the first half of the nineties in adult women,
mostly in urban settings, and little is known about adult
men or the growing elderly population as well as rural
obesity profiles.
In order to compose a comprehensive and updated
picture of the impact of obesity in Latin America, we have
established a multi-country consortium of obesity-related
epidemiological studies conducted in the region. This ini-
tiative constitutes a strategy aimed to efficiently identify
individual and population determinants of obesity, as well
as to assess the role of obesity on the burden of CVD. We
have chosen to focus on CVD for several reasons. First,
CVD is the leading cause of non-traumatic mortality in
Latin America (3,7); second, the projected burden of CVD
will double during the following 20 years in the region
(19,20); and third, there is a well-established association
between obesity and the incidence of major cardiovascular
risk factors and clinical cardiovascular events (21).
The specific objectives of the Latin American Consor-
tium of Studies in Obesity (LASO) are (i) To accurately
estimate the prevalence of obesity and its distribution by
sociodemographic characteristics in Latin America; (ii)
To identify ethnic, socioeconomic and behavioural factors
(nutritional and physical activity patterns) associated to
the prevalence of obesity; (iii) To estimate the association
between various anthropometric indicators of obesity and
classic cardiovascular risk factors and (iv) To quantify the
validity of standard definitions of obesity in this popula-
tion. Along with the accomplishment of these objectives, it
is expected that the consolidation of LASO will foster the
development of collaborative, harmonized studies on the
association between obesity and other relevant chronic dis-
eases in the region. LASO will help understand the obesity
epidemic and develop future studies to evaluate the deter-
minants and the impact of obesity in Latin America.
The aim of this manuscript is to present the protocol for
LASO, describe the use of standardized methodologies for
the pooling of data from individual studies and provide
a general description of participating studies and their
methodologies.
Materials and methodology
Identification and selection of studies
Studies included in LASO are cross-sectional or prospective
population-based cohort studies, based on random samples
of well defined free-living population. All studies have indi-
vidual data on demographic and socioeconomic indicators
and anthropometric indicators of obesity collected through
physical examination. Moreover, they have at least one of
the following (i) Direct measurement of major cardiovas-
cular risk factors; (ii) Determination of levels of physical
activity and (iii) Determination of nutritional patterns.
The search for potential participant studies is based on
computer-assisted literature searches of health-related data-
bases; hand-searching of obesity, cardiology, epidemiology
and other relevant journals; and personal communications
with cardiovascular and obesity researchers from the
region.
Ethical approval, informed consent and
confidentiality of the data
All studies have been approved by their respective local
Institutional Review Board, and all participants provided
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their informed consent. The investigators of the original
studies provide written consent for the use of their data
before transferring and inclusion into the Consortium’s
central database at the University of Wisconsin at Madison.
The data remain the property of the principal investigators
of each participant study and are securely stored in study-
dedicated computers. The central database does not include
codes or data that may directly or indirectly allow the
identification of individuals participating in the original
studies.
Consortium management and coordination
The LASO Steering Committee includes the principal inves-
tigators from all original studies. The tasks of this commit-
tee include (i) Coordinating the recruitment of new studies;
(ii) Developing and prioritizing research questions to be
addressed by the analysis of pooled data; (iii) Identifying
and securing funds for the study; (iv) Producing and dis-
seminating scientific reports of the ongoing research
projects among members of the Consortium and (v) Acting
as a publication committee. Parallel to the Steering Com-
mittee, a statistical centre has been constituted as an exter-
nal academic instance responsible for the creation and
management of the Consortium’s central database, as well
as for data analysis and generation of preliminary reports.
This centre is based at the Department of Population
Health Sciences, University of Wisconsin at Madison.
Study variables
Individual data collected in each study are categorized
in five domains (Table 1) (i) Demographics, including age,
gender, race or ethnic group; (ii) Indicators of socioeco-
nomic status, including socioeconomic stratification,
educational attainment, income, occupation and area of
residency; (iii) Anthropometric indicators of total and
regional obesity, measured by physical examination; (iv)
Classic cardiovascular risk factors, including measurements
of blood pressure and the laboratory assessment of glucose
and lipid fractions and (v) Behavioural risk factors, includ-
ing smoking status, alcohol consumption, physical activity
and nutritional intake. Continuous variables such as
anthropometric measures, blood pressure, glucose and lipid
fractions are categorized according to current standard
definitions. Whenever possible, categorical variables are
recoded following standard procedures to maximize com-
parability among studies. Data on study-specific proce-
dures are used to assess heterogeneity among studies.
Data transfer and checking
Password-protected data files are transferred from the indi-
vidual studies to the Consortium’s statistical centre using
electronic mailing. A codebook and a transference form
containing a list of parameters directly estimated from the
original datasets are included as part of the data transfer
protocol. For security purposes, the datasets and accompa-
nying files are encrypted before transferring using key-
words known only to the coordinator of the Consortium
and the principal investigators of each study. Specific
parameters calculated from each study after data transfer
are compared with those obtained by the study investiga-
tors before data transfer. In the case of inconsistencies, the
data are back-transferred to ensure identical results are
obtained with both datasets. The data are then converted to
a standard format and incorporated to the Consortium’s
central database.
Statistical analysis
Specific data analysis strategies are used for each specific
study using LASO data. However, some statistical proce-
dures are applied for all analyses. We use multivariate
imputation by chained equations to fill out missing values
within studies in order to minimize selection bias because
of missing data (22). Multiple imputed datasets are gener-
ated and the parameters of interest are averaged across
datasets, using Rubin’s formula (23). In addition, we use
post-stratification by the age and gender distribution of the
Table 1 Variables available in the Latin American Consortium of Studies
in Obesity (LASO)
Domain Variable (description)
Demographic Age (years); gender (male/female)
Ethnicity (Amerindian/Black/White/other)
Socioeconomic Educational attainment (highest level or total years)
Income (individual or household)
Occupation (occupational categories)
Area of residency (urban/rural)
Anthropometry* Body weight (kg)/height (m)
Waist circumference (cm)
Hip circumference (cm)
Cardiovascular
and metabolic
risk factors*
Systolic/diastolic blood pressure (mmHg)
Glucose (mmol L-1)
Total, HDL and LDL cholesterol (mmol L-1)
Triglycerides (mmol L-1)
Behavioural
risk factors
Smoking status (never, past or current; cigarettes
per day)
Alcohol consumption (type of beverage, frequency
and quantity)
Physical activity (type of activity, frequency and
duration)
Foods/nutrients’ intake (food frequency
questionnaires)
*Measured by physical examination or laboratory analysis.
HDL, high-density lipoprotein; LDL, low-density lipoprotein.
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whole population in the countries included in the specific
analysis as a way to minimize bias resulting from non-
response and sampling frame under-coverage (24). Post-
strata are constructed using the population totals by
country, gender and age group (20–29, 30–39, 40–49,
50–59, 60–69, 70–79 and 80 years and older). Population
distribution data are obtained from the U.S. Census Bureau
(http://www.census.gov) for Puerto Rico and from the
Centro Latinoamericano y Caribeño de Demografía –
CELADE (http://www.cepal.org.ar/Celade) for all other
countries.
Multiple weighted linear and logistic regression are
implemented in order to (i) Compare the distribution of
anthropometric indicators and the prevalence of obesity
and cardiovascular risk factors in groups defined by demo-
graphic and socioeconomic characteristics; (ii) Predict the
prevalence of total and regional obesity in these groups and
(iii) Quantify the independent effect of total and regional
obesity on the distribution of individual cardiovascular risk
factors and coronary heart disease risk. In order to deter-
mine which anthropometric indicator of obesity better
identifies individuals with specific cardiovascular risk
factors or who are at high risk of coronary heart disease,
we estimate and compare the areas under the receiver
operator characteristic (ROC) curves using the method of
placement values (25,26). Finally, optimal cut-points for
the anthropometric indicators of obesity are also deter-
mined on the basis of the ROC analysis by estimating the
values of the indicator that minimize the cost of misclassi-
fying individuals according to the presence of specific car-
diovascular risk factors or the risk of coronary heart
disease (27).
Publication policy
Manuscripts derived from the analysis of aggregated data
undergo an internal peer-review process. Manuscripts cir-
culate among the members of the Steering Committee, who
provide comments and generate a feedback report to the
main authors. The main author addresses and responds to
the comments and prepares a final revised version. LASO’s
Steering Committee approves the final manuscript before
submission. Finally, as part of a strategy of communica-
tion and recruitment, the Consortium has developed a
website (http://www.pophealth.wisc.edu/laso), which con-
tains general information on the participant studies, the
principal investigators and their groups, and links to the all
the publications derived from the analysis of pooled data.
Results
Eleven studies (28–38) from eight countries in Latin
America and the Caribbean (Argentina, Chile, Colombia,
Costa Rica, Dominican Republic, Peru, Puerto Rico and
Venezuela) are currently included in the LASO, including a
total of 32 462 subjects (Table 2). The overall mean age is
45.8 years (standard deviation 18.6 years; range: 15–109
years) and the male proportion is 40.6%, ranging from
31.0% to 50%. Four studies are national health surveys
(29,32–34), but one of them is restricted to urban popula-
tion (33). In addition, one study was conducted at the state
level (38), five exclusively targeted urban populations from
single cities (28,30,31,36,37) and other sampled an urban
and a rural population (35).
Data on demographic and socioeconomic characteristics,
smoking, medical history and current treatment of hyper-
tension and diabetes were collected by trained interviewers
using similar questionnaires (available to the members of
the statistical centre) in all studies. Standing height and
weight were measured in all surveys with the participants
wearing light clothing and no shoes. Waist circumference
was measured at the umbilical level in five studies
(28,31,32,36,38), at the midpoint between the lowest rib
and the iliac crest in four studies (29,30,34,35), at the high
Table 2 Characteristics of the studies from the Latin American Consortium of Studies in Obesity (LASO)
Study Location Year Target Sample Age Male
Encuesta de Factores de Riesgo (28) Argentina, Ushuaia/Rio Grande 2003–2004 City 1135 18–65 48%
Encuesta Nacional de Salud (29) Chile 2003 National 3619 16–97 45%
CARMEN (30) Colombia, Bogotá 2001 City 2962 15–69 43%
CARMEN (31) Colombia, Bucaramanga 2001 City 2994 15–66 36%
CRELES (32) Costa Rica 2004–2006 National 2826 60–109 46%
EFRICARD (33) Dominican Republic 1998 National (urban) 6184 18–75 34%
ENINBSC-ECNT (34) Peru 2005 National 4209 20–95 50%
PERU MIGRANT (35) Peru, Lima/Ayacucho 2007–2008 Urban/rural 990 29–92 47%
PREVENCION (36) Peru, Arequipa 2004–2006 City 1878 20–80 46%
Metabolic syndrome in San Juan (37) Puerto Rico 2005–2007 City 865 21–79 35%
The Zulia CHD Factor Study (38) Venezuela, Zulia 1999–2001 State 4800 20–97 31%
CHD, coronary heart disease.
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point of the iliac crest in one study (37), and was not
measured in one study (33). Hip circumference was mea-
sured at the maximum extension of the buttocks. Blood
pressure measurements were conducted at least twice in all
but one study (34), following standard recommendations
(39). Blood samples were obtained in all studies after 8 h
of fast. Blood glucose, total cholesterol and high-density
lipoprotein cholesterol were measured enzymatically by
automated methods. Low-density lipoprotein (LDL) cho-
lesterol was directly measured in two studies (36,38)
and was calculated using the Friedewald equation (40)
otherwise.
For effects of statistical analyses, hypertension is defined
as a systolic blood pressure 140 mmHg, or as a diastolic
blood pressure 90 mm Hg, or as current anti-
hypertensive treatment, and participants are considered
diabetics if their fasting glucose is 7.0 mmol L-1
(126 mg dL-1) or if they report current pharmacological
treatment for diabetes (either insulin or oral agents).
High total cholesterol is defined as a total cholesterol
6.15 mmol L-1 (240 mg dL-1). High LDL cholesterol
and low high-density lipoprotein cholesterol are deemed
present if the corresponding cholesterol levels are 4.10
(160 mg dL-1) and <1.03 mmol L-1 (<40 mg dL-1), respec-
tively. Hypertriglyceridemia is defined as a level of triglyc-
erides 2.25 mmol L-1 (200 mg dL-1). Also, participants
are classified as current smokers if they report to have
smoked at least 100 cigarettes in their lives and have
smoked during the previous 1–6 months in two studies
(30,35) or if they were smoking at least one cigarette per
day at the moment of the evaluation in the remaining
studies. Overall obesity is defined as body mass index
30 kg m-2 and abdominal obesity as a waist circumfer-
ence 88 cm in women and 102 cm in men, following
the recommendations of the World Health Organiza-
tion (6).
Finally, as a strategy to summarize the cardiovascular
risk, the expected 10-year risk of coronary heart disease is
estimated in men and women 30–74 years old by using the
Framingham equation (41). Considering that the equation
may overestimate the absolute risk of coronary heart
disease (CHD) in Latin Americans (42), we use the
population-specific mean values for the risk factors in order
to minimize such effect. Participants with an estimated
10-year risk of CHD 20% are considered at ‘high risk’,
because current standards of care recommend aggressive
risk reduction and selective use of proven drug therapies in
these individuals (43,44).
Conclusion
The LASO constitutes a multinational initiative to effi-
ciently assess the public health problem of obesity, its socio-
demographic and behavioural determinants, and its impact
on the risk of CVD in the region. The strategy of combining
data captured at individual level from population-based
studies will allow not only to increase precision in estimat-
ing the prevalence of obesity, but also to capture the het-
erogeneity of the effect of this condition on the health of the
Latin American population. Finally, the Consortium, which
currently includes data from 11 studies involving approxi-
mately 33 000 participants, will serve as framework for the
interchange of observational data, discussion and interpre-
tation of regional epidemiological evidence, and ultimately
the formulation of high-quality, standardized, collaborative
proposals on obesity and other prevalent chronic diseases.
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